tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

FGEN Stock Latest News

FibroGen granted orphan drug designation for roxadustat in MDS
The FlyFibroGen granted orphan drug designation for roxadustat in MDS
12d ago
FGEN
FibroGen’s Earnings Call: Strategic Moves Amid Financial Caution
PremiumCompany Announcements
FibroGen’s Earnings Call: Strategic Moves Amid Financial Caution
2M ago
FGEN
FibroGen’s Strategic Moves and Financial Outlook: Hold Rating Amid Uncertainties
PremiumRatings
FibroGen’s Strategic Moves and Financial Outlook: Hold Rating Amid Uncertainties
2M ago
FGEN
FibroGen’s Strategic Moves and Financial Highlights
PremiumCompany Announcements
FibroGen’s Strategic Moves and Financial Highlights
2M ago
FGEN
FibroGen reports Q3 EPS ($3.25), consensus ($4.01)
PremiumThe Fly
FibroGen reports Q3 EPS ($3.25), consensus ($4.01)
2M ago
FGEN
FGEN Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsFGEN Upcoming Earnings Report: What to Expect?
2M ago
FGEN
FibroGen Receives $6.4 Million Payment from AstraZeneca
Premium
Company Announcements
FibroGen Receives $6.4 Million Payment from AstraZeneca
2M ago
8K
FGEN
Hold Rating on FibroGen’s FG-3246 Amid Competitive Prostate Cancer Treatment Landscape and Upcoming Trial Data
Premium
Ratings
Hold Rating on FibroGen’s FG-3246 Amid Competitive Prostate Cancer Treatment Landscape and Upcoming Trial Data
2M ago
FGEN
FibroGen’s Strategic and Financial Advancements: A Positive Outlook on FG-3246 and Roxadustat
PremiumRatings
FibroGen’s Strategic and Financial Advancements: A Positive Outlook on FG-3246 and Roxadustat
3M ago
FGEN
FibroGen initiates Phase 2 trial of FG-3246
PremiumThe Fly
FibroGen initiates Phase 2 trial of FG-3246
3M ago
FGEN
SEC charges former FibroGen CMO for false claims on clinical trial results
PremiumThe Fly
SEC charges former FibroGen CMO for false claims on clinical trial results
4M ago
FGEN
FibroGen Sells Subsidiary to AstraZeneca for $220 Million
PremiumCompany Announcements
FibroGen Sells Subsidiary to AstraZeneca for $220 Million
4M ago
8K
FGEN
FibroGen’s Strategic Moves and Clinical Prospects Drive Buy Rating
PremiumRatingsFibroGen’s Strategic Moves and Clinical Prospects Drive Buy Rating
4M ago
FGEN
FibroGen Sells Subsidiary to AstraZeneca for $220M
Premium
Company Announcements
FibroGen Sells Subsidiary to AstraZeneca for $220M
4M ago
8K
FGEN
FibroGen completes sale of FibroGen China to AstraZeneca for $220M
Premium
The Fly
FibroGen completes sale of FibroGen China to AstraZeneca for $220M
4M ago
AZN
FGEN
FibroGen’s Earnings Call Highlights Strategic Advances and Financial Challenges
PremiumCompany Announcements
FibroGen’s Earnings Call Highlights Strategic Advances and Financial Challenges
4M ago
FGEN
FibroGen Gains Approval for Subsidiary Sale to AstraZeneca
PremiumCompany Announcements
FibroGen Gains Approval for Subsidiary Sale to AstraZeneca
4M ago
8K
FGEN
FibroGen announces approval for FibroGen China sale to AstraZeneca
PremiumThe Fly
FibroGen announces approval for FibroGen China sale to AstraZeneca
4M ago
AZN
FGEN
FibroGen Amends Financing Agreement with Morgan Stanley
PremiumCompany Announcements
FibroGen Amends Financing Agreement with Morgan Stanley
5M ago
8K
FGEN
FibroGen’s Strong Financial Position and Promising Clinical Pipeline Drive Buy Rating
PremiumRatingsFibroGen’s Strong Financial Position and Promising Clinical Pipeline Drive Buy Rating
5M ago
FGEN
FibroGen’s Hold Rating: Balancing Drug Development Progress and Financial Outlook
Premium
Ratings
FibroGen’s Hold Rating: Balancing Drug Development Progress and Financial Outlook
5M ago
FGEN
FibroGen’s Strategic Moves and Financial Outlook
Premium
Company Announcements
FibroGen’s Strategic Moves and Financial Outlook
5M ago
FGEN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >